Publications by authors named "Catherine Harrington"

Article Synopsis
  • - Psilocybin has shown promise in treating depression and anxiety, but most studies have focused on its effectiveness rather than its safety.
  • - This objective of this research was to assess the acute adverse effects of psilocybin at therapeutic doses in individuals with these mental health conditions.
  • - The study found that out of six clinical trials involving 528 participants, several adverse effects were reported, including headache, nausea, anxiety, and dizziness, with varying degrees of risk associated with psilocybin treatment.
View Article and Find Full Text PDF

Introduction: To assess the extent pharmacy programs are offering courses in management and marketing.

Methods: We sampled the extent of management and marketing coursework in the doctor of pharmacy (PharmD) curricula in the United States (US) by examining website descriptions of the best pharmacy schools in 2020 (N = 134) as ranked by the US News and World report. Links to curriculum descriptions and catalogs were reviewed for coursework having the words, marketing, management, entrepreneurship, or business plan in the title.

View Article and Find Full Text PDF

Background And Purpose: To gauge the potential effect of mode of content delivery on overall student success in a pharmaceutical sciences course in a doctor of pharmacy program.

Educational Activity And Setting: Principles of Drug Action I (PDAI) is a first-year pharmaceutical science course typically taught by multiple faculty, and each utilizes their own approach to deliver course content. Over a seven year period, the course naturally separated into blocks.

View Article and Find Full Text PDF

Purpose: Chronic kidney disease (CKD) is a common complication among patients with diabetes mellitus; however, noncompliance with the recommended annual screening is common. Increased screening among high-risk patients is important to identify the early stages CKD, potentially resulting in earlier treatment, slower progression, fewer complications, and decreased healthcare expenditures. Motivational interviewing (MI) has previously been shown to be effective for various behaviors, such as smoking cessation and cholesterol level control.

View Article and Find Full Text PDF

Objective: To evaluate the association between the level of vitamin D and glycemic control among patients with diabetes.

Research Design And Method: We analyzed data collected from NHANES 2003-2006. We included only non-pregnant adult diabetic persons 18 years or older.

View Article and Find Full Text PDF

There are limited resources available for pharmacists and doctors to reference proper compounded formulas for pain medications. The systematic review discussed within this article provides the foundation for a searchable database, allowing users to find various compounded formulations. It also provides data about the safety and efficacy of the preparations.

View Article and Find Full Text PDF

Objective: This updated meta-analysis determines the effect of dipeptidyl peptidase-4 inhibitors on glycemic and tolerability outcomes in patients with type 2 diabetes mellitus and chronic kidney disease with glomerular filtration rate of ⩽60 mL/min or on dialysis.

Methods: In all, 14 citations were identified from multiple databases. Qualitative assessments and quantitative analyses were performed.

View Article and Find Full Text PDF

CVS Health has taken a strategic marketing move by banning tobacco sales. They risk losing customers who buy medications and cigarettes at their drugstores. They estimate they will lose 2 billion dollars by banning cigarette sales.

View Article and Find Full Text PDF

Akathisia is a troubling side effect that leads to non-adherence with antipsychotic regimens. Second generation antipsychotics (SGAs) tend to cause less akathisia than older agents but the risk still exists and rates vary between agents. Little is known about the incidence of akathisia among the newer SGAs.

View Article and Find Full Text PDF

Background: Bipolar disorder (BD) is a chronic, relapsing, episodic mental illness associated with other psychiatric comorbidities. There is a substantial economic burden with BD, which makes it challenging to treat. The aim of this review is to evaluate the pharmacology, clinical efficacy, and safety data related to paliperidone extended release (ER) for the treatment of BD.

View Article and Find Full Text PDF

Study Objective: To assess the drug-related risk of adverse events associated with ziprasidone.

Design: Meta-analysis of 19 randomized, placebo-controlled trials.

Patients: A total of 4132 adults taking oral ziprasidone who had adverse-event data reported in the studies identified.

View Article and Find Full Text PDF

Since their founding in 2000, retail-based health care clinics, also called convenient care clinics, have flourished but continue to generate controversy. This article examines the literature with respect to the industry's background, establishment of industry standards, types of services offered, marketing of retail health clinics, industry growth with new target markets, and patient demographics. It also examines the growing relationship with insurers and third-party payers, quality-of-care concerns by medical associations, and legal regulations and their potential impact on industry growth nationwide.

View Article and Find Full Text PDF

Pharmaceutical manufacturer labels are an important source of adverse drug event (ADE) information. The study objective was to determine the sufficiency of ADE reporting in US drug labels. A sample of 50 labels was evaluated from the top 200 drugs dispensed in the US.

View Article and Find Full Text PDF

Balancing tolerability and efficacy of medications can be problematic for clinicians when assessing appropriate therapy for patients. For antipsychotic therapy, this can be especially challenging because of the hazardous movement and metabolic effects associated with them. Paliperidone is an atypical antipsychotic used for the treatment of schizophrenia and schizoaffective disorder.

View Article and Find Full Text PDF

In Medicaid, generic drug cost containment revolves around two programs: the Federal upper limit (FUL) program and State maximum allowable cost (MAC) programs. This article analyzes MAC programs in five States and finds considerable variation between these programs and the FUL program in both size and pricing aggressiveness. We conclude that expansion of existing MAC programs and creation of new ones could contribute to cost containment efforts nationwide.

View Article and Find Full Text PDF